Stockscreener 앱 받기
3.00
3.85%
-0.12
전일 마감가:
$3.12
열려 있는:
$3.1
하루 거래량:
5,136
Relative Volume:
0.11
시가총액:
$9.53M
수익:
-
순이익/손실:
$-7.29M
주가수익비율:
-0.1231
EPS:
-24.3686
순현금흐름:
$-6.81M
1주 성능:
+0.33%
1개월 성능:
-0.99%
6개월 성능:
-14.53%
1년 성능:
-21.16%
1일 변동 폭
$3.00
$3.126
1주일 범위
$3.00
$3.25
52주 변동 폭
$2.01
$6.47
Heartsciences Inc Stock (HSCS) Company Profile
명칭
Heartsciences Inc
전화
682-237-7781
주소
550 RESERVE ST, SUITE 360, SOUTHLAKE
Compare HSCS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HSCS
Heartsciences Inc
|
3.00 | 9.92M | 0 | -7.29M | -6.81M | -24.37 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Heartsciences Inc 주식(HSCS)의 최신 뉴스
Will HeartSciences Inc. Equity Warrant benefit from geopolitical trendsJuly 2025 Levels & Precise Swing Trade Alerts - mfd.ru
Can HeartSciences Inc. Equity Warrant stock beat market expectations this quarterPortfolio Return Report & Free Safe Entry Trade Signal Reports - mfd.ru
Breakout Move: Is HeartSciences Inc. Equity Warrant attractive for institutional investorsMarket Growth Review & Stock Timing and Entry Methods - mfd.ru
How HeartSciences Inc. Equity Warrant stock valuations compare to rivalsJuly 2025 PreEarnings & Weekly Return Optimization Plans - mfd.ru
What are HeartSciences Inc. Equity Warrant’s earnings expectationsEarnings Risk Summary & Low Risk Entry Point Guides - mfd.ru
Market Review: What are HeartSciences Inc Equity Warrants earnings expectationsJuly 2025 Fed Impact & Safe Capital Growth Stock Tips - baoquankhu1.vn
Market Outlook: Whats the fair value of LINKBANCORP Inc stock2025 Fundamental Recap & Weekly Return Optimization Alerts - baoquankhu1.vn
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center - The Manila Times
HeartSciences Partners with University of the West of England to Establish Exclusive ECG Education and Technology Reference Center - Quiver Quantitative
UK university bets on AI ECG to train future NHS heart specialists - Stock Titan
Earnings Risk: Is HeartSciences Inc part of any ETFJuly 2025 Momentum & AI Forecasted Stock Moves - baoquankhu1.vn
Is HeartSciences Inc. Equity Warrant in a long term uptrendTrade Volume Report & Free Community Consensus Stock Picks - mfd.ru
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals - The Manila Times
123 community hospitals move to cloud ECG platform in new HeartSciences–Cibolo deal - Stock Titan
Panic Selling: Can HeartSciences Inc Equity Warrant sustain its profitabilityWeekly Profit Analysis & Safe Capital Growth Tips - baoquankhu1.vn
Growth Value: Will Investors Title Company outperform the market in YEARForecast Cut & Short-Term High Return Ideas - baoquankhu1.vn
Risks Report: Can HeartSciences Inc Equity Warrant ride the EV waveJuly 2025 Snapshot & Weekly High Momentum Picks - baoquankhu1.vn
Trend Review: Is HeartSciences Inc Equity Warrant attractive for institutional investorsJuly 2025 News Drivers & Fast Gain Swing Trade Alerts - baoquankhu1.vn
HeartSciences Secures New Private Financing Through Note Issuance - TipRanks
HeartSciences Signs Note Purchase Agreement With Streeterville Capital - TradingView
Trend Report: How HeartSciences Inc Equity Warrant stock reacts to oil pricesJuly 2025 Reactions & Real-Time Chart Breakout Alerts - Bộ Nội Vụ
HeartSciences Inc. announced that it has received $3 million in funding - marketscreener.com
Will HeartSciences Inc. Equity Warrant stock recover faster than peersJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - Улправда
Why hedge funds are buying HeartSciences Inc. Equity Warrant stockWeekly Profit Report & Fast Momentum Stock Entry Tips - Улправда
What hedge fund activity signals for HeartSciences Inc. Equity Warrant stockJuly 2025 Chart Watch & Verified Stock Trade Ideas - Улправда
Why HeartSciences Inc. Equity Warrant stock remains resilientMarket Performance Recap & High Return Trade Opportunity Guides - ulpravda.ru
Why HeartSciences Inc. Equity Warrant stock appeals to dividend seekersJuly 2025 News Drivers & Scalable Portfolio Growth Methods - ulpravda.ru
Can HeartSciences Inc. stock deliver sustainable ROEWeekly Earnings Recap & Growth Focused Entry Point Reports - Улправда
Will HeartSciences Inc. stock recover faster than peers2025 Sector Review & Momentum Based Trading Signals - Улправда
Is HeartSciences Inc. stock a safe haven asset2025 Volatility Report & Fast Gaining Stock Reports - Улправда
Buyout Rumor: Why HeartSciences Inc. Equity Warrant stock remains resilientJuly 2025 Chart Watch & High Conviction Buy Zone Picks - ulpravda.ru
Published on: 2026-01-12 22:13:00 - ulpravda.ru
Is HeartSciences Inc. Equity Warrant stock supported by strong cash flows2026 world cup usa national team group stage defensive leaders transition play odds analysis expert opinion - ulpravda.ru
What analysts say about HeartSciences Inc Equity Warrant stockMarket Depth Overview & Free Technical Analysis and Insights - Early Times
Market Meltdown the Virus and our ActionablesStock Price Divergence & Affordable Trading Strategies - bollywoodhelpline.com
Going all in on OTM options with low probabilities.Price Support Zones & Access Powerful Market Insights - bollywoodhelpline.com
Indo Count Industries Limited (ICIL) Expands into New MarketPrice-to-Book Ratio Updates & Exceptional Capital Growth - bollywoodhelpline.com
HeartSciences (NASDAQ:HSCS) Price Target Raised to $9.20 at Ascendiant Capital Markets - Defense World
HeartSciences (NASDAQ:HSCS) and Movano (NASDAQ:MOVE) Critical Survey - Defense World
Ascendiant Capital Maintains HeartSciences (HSCS) Buy Recommendation - Nasdaq
HeartSciences (HSCS) Receives Updated Analyst Rating and Price T - GuruFocus
HeartSciences (NASDAQ:HSCS) & Health Catalyst (NASDAQ:HCAT) Critical Analysis - Defense World
Does HeartSciences Inc. stock trade at a discount to peersJuly 2025 Spike Watch & Verified Swing Trading Watchlists - Улправда
Is HeartSciences Inc. Equity Warrant stock a top pick in earnings seasonEarnings Recap Report & Low Risk High Reward Ideas - Улправда
Why HeartSciences Inc. Equity Warrant stock could see breakout soon2025 Sector Review & Fast Entry High Yield Tips - Улправда
Will HeartSciences Inc. Equity Warrant stock attract ESG investorsMarket Weekly Review & Long Hold Capital Preservation Plans - Улправда
Will HeartSciences Inc. Equity Warrant stock deliver shareholder valueJuly 2025 Price Swings & Advanced Swing Trade Entry Plans - Улправда
History Review: Does HeartSciences Inc. stock trade at a discount to peers2025 Major Catalysts & Real-Time Volume Triggers - Улправда
Heartsciences Inc (HSCS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
0.51%
자본화:
|
볼륨(24시간):